IHC analysis of continuous sections showed that PDGFR-β, p-GSK, p-P65 were co-expressed in cancer cells, and showed especially high levels in tumors from patients with LN+CCA (Fig. 10A). This evidence concerns the gene PDGFRB and cholangiocarcinoma.